CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-24 | Schenkein David P Chief Executive Officer | Option exercise | +13,533 | $0.30 | $4K | 13,533 |
| 2018-01-24 | Schenkein David P Chief Executive Officer | Sale | −13,533 | $80.01 | $1.1M | 0 |
| 2018-01-24 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −13,533 | 141,159 | ||
| 2018-01-23 | CELGENE CORP /DE/ 10% owner | Purchase | +851,154 | $67.00 | $57.0M | 1,374,599 |
| 2018-01-23 | Hoerter Steven L. Chief Commercial Officer | Option exercise · Stock option (right to buy) | −25,000 | 75,000 | ||
| 2018-01-23 | Hoerter Steven L. Chief Commercial Officer | Option exercise | +25,000 | $39.76 | $994K | 25,000 |
| 2018-01-23 | Hoerter Steven L. Chief Commercial Officer | Sale | −25,000 | $74.83 | $1.9M | 0 |
| 2018-01-23 | Hoerter Steven L. Chief Commercial Officer | Option exercise · Stock option (right to buy) | +25,000 | 75,000 | ||
| 2018-01-23 | Schenkein David P Chief Executive Officer | Option exercise | +32,875 | $0.30 | $10K | 32,875 |
| 2018-01-23 | Schenkein David P Chief Executive Officer | Sale | −32,875 | $80.01 | $2.6M | 0 |
| 2018-01-23 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −32,875 | 5,962 | ||
| 2018-01-23 | CELGENE CORP /DE/ 10% owner | Purchase | +851,154 | $67.00 | $57.0M | 1,374,599 |
| 2018-01-16 | Schenkein David P Chief Executive Officer | Option exercise | +53,000 | $0.30 | $16K | 53,000 |
| 2018-01-16 | Schenkein David P Chief Executive Officer | Sale | −13,185 | $71.77 | $946K | 39,815 |
| 2018-01-16 | Schenkein David P Chief Executive Officer | Sale | −22,304 | $73.02 | $1.6M | 17,511 |
| 2018-01-16 | Schenkein David P Chief Executive Officer | Sale | −10,914 | $74.11 | $809K | 6,597 |
| 2018-01-16 | Schenkein David P Chief Executive Officer | Sale | −6,597 | $74.80 | $493K | 0 |
| 2018-01-16 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −53,000 | 154,692 | ||
| 2018-01-12 | Alenson Carman Principal Accounting Officer | Option exercise | +2,150 | $52.29 | $112K | 2,150 |
| 2018-01-12 | Alenson Carman Principal Accounting Officer | Sale | −2,150 | $75.00 | $161K | 0 |
Page 68 of 80 · 1,590 trades